RecruitingPHASE2, PHASE3NCT01949129

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Studying Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
St. Anna Kinderkrebsforschung
Principal Investigator
Christina Peters, Prof. MD PhD, M.D
St. Anna Kinderspital, Vienna, Austria
Intervention
VP16(drug)
Enrollment
1800 enrolled
Eligibility
18 years · All sexes
Timeline
20132030

Study locations (30)

Collaborators

ALL SCTped Forum · European Society for Blood and Marrow Transplantation · ALL-BFM Study Group · Assistance Publique - Hôpitaux de Paris · Dutch Childhood Oncology Group · Swiss Pediatric Oncology Group · Australian & New Zealand Children's Haematology/Oncology Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01949129 on ClinicalTrials.gov

Other trials for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement

Additional recruiting or active studies for the same condition.

See all trials for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement

← Back to all trials